Phase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma Meeting Abstract


Authors: Krebs, M.; Lopez, J.; El-Khoueiry, A.; Bang, Y. J.; Postel-Vinay, S.; Abidah, W.; Im, S. A.; Khoja, L. T.; Standifer, N.; Jones, G. N.; Marco-Casanova, P.; Frewer, P.; Berges, A.; Cheung, A.; Stephens, C.; Felicetti, B.; Dean, E.; Pierce, A.; Hollingsworth, S.
Abstract Title: Phase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy279.401
Language: English
ACCESSION: WOS:000459277300404
PROVIDER: wos
DOI: 10.1093/annonc/mdy279.401
Notes: Meeting Abstract: 413PD -- Appears on page viii135 of the abstract book -- W. Abida's last name is misspelled on the original publication -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Wassim Abida
    154 Abida